# Salish Bioscience Inc. — Form D

Salish Bioscience Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-14. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-04-14
- Form: D
- Accession: 0001922451-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 25
- Date of first sale: 2022-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441884

## Issuer

- Name: Salish Bioscience Inc.
- CIK: 0001922451
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2021
- Address: 3005 1st Avenue Suite 204, SEATTLE, WA, 98121
- Phone: 2068496038

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kira Misura | Director | Seattle, WA |
| Frank Paganelli | Director | Woodinville, WA |
| Chris Raymond | Director | Seattle, WA |
| Fenella Raymond | Director | Seattle, WA |
| Frank Paganelli | Executive Officer | Woodinville, WA |
| Fenella Raymond | Executive Officer | Seattle, WA |

## More

- [CIK 1922451 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1922451&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001922451-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.